Multi-resistant Acinetobacter baumannii emergence associated with healthcare infections: Meta-analysis
DOI:
https://doi.org/10.33448/rsd-v9i10.8270Keywords:
Acinetobacter baumanni; Resistance; MDR.Abstract
The high resistance to antimicrobials has made hospitals a potentially dangerous environment for the development of HAIs, especially when associated with multi-resistant bacteria such as A. baumannii. The work aimed to evaluate the incidence of multidrug-resistant Acinetobacter baumannii described in the literature through a meta-analysis. A meta-analysis of a qualitative and quantitative nature was carried out in which original articles and review articles that presented data on the occurrence and existence of multidrug resistance in Acinetobacter baumannii were evaluated. The Scientific Electronic Library on Line (SciELO) and Medical Literature Analysis and Retrieval System Online (Pubmed / MEDLINE) databases were consulted using the descriptors "Acinetobacter baumannii," "multi-resistance," "IRAS," "incidence." Most studies were carried out in 2018. In general, most studies were cross-sectional 85.00% (n = 17) and cohort 15.00% (n = 3). In the selected studies, 5877 cases were reported, of which 3544 corresponded to multi-resistant species of Acinetobacter. The cumulative prevalence ratio corresponded to 0.603 with a 95% confidence interval [0.590 to 0.615]. The analysis of the temporal trend of the Ratio of the prevalence of multidrug-resistant Acinetobacter baumanni according to the year of the selected studies indicated that the PR suffered a decline in 2009 and 2013 and a new tendency to increase from 2015 and suffered small fluctuations until 2019, the trend did not show significant (R2 = 0.0772). Therefore, the MDR profile is worrying, given the currently available therapeutic alternatives.
References
National Health Surveillance Agency [Agência Nacional de Vigilância Sanitária - ANVISA]. (2017a). National Plan for the Prevention and Control of Microbial Resistance in Health Services [Plano Nacional para a Prevenção e o Controle da Resistência Microbiana nos Serviços de Saúde]. Brasília. Retrieved from: http://portal.anvisa.gov.br/documents/33852/271855/Plano+Nacional+para+a+Prevenção+e+o+Controle+da+Resistência+Microbiana+nos+Serviços+de+Saúde/9d9f63f3-592b-4fe1-8ff2-e035fcc0f31d
National Health Surveillance Agency [Agência Nacional de Vigilância Sanitária - ANVISA]. (2017b). National Guideline for the Elaboration of a Management Program for the Use of Antimicrobials in Health Services [Diretriz Nacional para Elaboração de Programa de Gerenciamento do Uso de Antimicrobianos em Serviços de Saúde. Brasília]. Retrieved from: http://portal.anvisa.gov.br/documents/33852/271855/Diretriz+Nacional+para+Elaboração+de+Programa+de+Gerenciamento+do+Uso+de+Antimicrobianos+em+Serviços+de+Saúde/667979c2-7edc-411b-a7e0-49a6448880d4
Araújo B. T., & Pereira, D. C. R. (2018). Policies for control Health Care-Related Infections (IRAS) in Brazil, 2017. Ciências Saúde, 28(4), 333 342. Retrieved from http://www.escs.edu.br/revistaccs/index.php/comunicacaoemcienciasdasaude/article/view/275
Araújo, P. L., Mendonça, A. E. O., Medeiros, R. A., Souza Neto, V. L., Nobre, T. T. X., & Costa, I. K. F. (2017). Prevalence of health assistance infection in patients hospitalized in intensive therapy unit. Enfermería Global, 52, 304-315. doi:10.6018/eglobal.17.4.289311
Arroyo, L. A., Mateos, I., González, V., & Aznar, J. (2009). In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group. Antimicrobial agents and chemotherapy, 53(3), 1295–1296. doi:10.1128/AAC.01097-08
Asadollahi, K., Alizadeh, E., Akbari, M., Akbari, M., Taherikalani, M., Niakan, M., Maleki, A., Asadollahi, P., Soroush, S., Feizabadi, & Emaneini, M. (2011). The role of bla(OXA-like carbapenemase) and their insertion sequences (ISS) in the induction of resistance against carbapenem antibiotics among Acinetobacter baumannii isolates in Tehran hospitals. Roum Arch Microbiol Immunol, 70(4), 153-158. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/22568262/
Ballot, D. E., Nana, T., Sriruttan, C., & Cooper, P. A. (2012). Bacterial bloodstream infections in neonates in a developing country. ISRN pediatrics, 2012, 1-7. doi:10.5402/2012/508512
Boroumand, M. A., Akhyani, H., Sheikhvatan, M., Hekmat Yazdi, S., Saboorian, R., Hashemi, Sh., Firouzkouhi, F. (2009). Evaluation of Antimicrobial Resistance of Acinetobacter baumannii to Imipenem, Ciporofloxacin and Ceftazidime using E Test. Iranian J Publ Health, 38 (2), 130-133. Retrieved from: file:///E:/acineto/Evaluation_of_Antimicrobial_Resistance_of_Acinetob.pdf
Chagas, T. P. G. (2015). Characterization of multidrug-resistant OXA- and NDM-type carbapenemase producing Acinetobacter spp. isolated from different Brazilian regions. Doctoral thesis, Oswaldo Cruz Foundation, Oswaldo Cruz Institute, Rio de Janeiro, RJ, Brazil.
Chen, L., Mathema, B., Chavda, K. D., DeLeo, F. R., Bonomo, R. A., & Kreiswirth, B. N. (2014). Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding. Trends in microbiology, 22(12), 686–696. doi:10.1016/j.tim.2014.09.003
Dalmasio, S. M. R. (2018). Epidemiological aspects of the dissemination of the species Acinetobacter baumannii for the control of health care related infections: a literature review [Aspectos epidemiológicos da disseminação da espécie Acinetobacter baumannii para controle de infecções relacionadas à assistência à saúde: uma revisão de literatura]. Master's Dissertation, Department of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais, Minas Gerais, MG, Brazil.
Gales, A. C., Castanheira, M., Jones, R. N., & Sader, H. S. (2012). Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010). Diagnostic microbiology and infectious disease, 73(4), 354–360. doi:10.1016/j.diagmicrobio.2012.04
Genteluci, G. L. (2016). Study of genetic polymorphism, resistance and virulence factors in Acinetobacter baumannii isolates collected from two public hospitals in the city of Rio de Janeiro between 2010 and 2011 [Estudo do polimorfismo genético, resistência e fatores de virulência em isolados de Acinetobacter baumannii coletados de dois hospitais da rede pública do município do Rio de Janeiro entre 2010 e 2011]. Master's Dissertation, National Institute of Quality Control in Health, Oswaldo Cruz Foundation, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Gholami, M., Moshiri, M., Ahanjan, M., Salimi Chirani, A., Hasannejad Bibalan, M., Asadi, A., Eshaghi, M., Pournajaf, A., Abbasian, S., Kouhsari, E., & Irajian, G. (2018). The diversity of class B and class D carbapenemases in clinical Acinetobacter baumannii isolates. Le infezioni in medicina, 26(4), 329–335. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/30555136/
Godoy, C. S. M. (2012). Acinetobacter baumannii infections in adults admitted to intensive care units in the Goiânia and Aparecida de Goiânia city of Brazil. Dissertation for Masters, Institute of Tropical Pathology and Public Health, Federal University of Goiás - UFG, Goiás, Goiânia, GO, Brazil.
Gomes, A. C., Carvalho, P. O., Lima, E. T. A., Gomes, E. T., Valença, M. P., & Cavalcanti, A. T. A. (2014). Characterization of infections related to health care in the intensive care unit. Enfermagem UFPE On Line, 8(6), 1577-85. doi:10.5205/reuol.5876-50610-1-SM.0806201417
Gomes, D. B. C., GenteluciI, G. L., Carvalho, K. R., Medeiros, L. M., Almeida, V. C., Castro, E. A. R. & Villas-Bôas, M. H. S. (2016). Multidrug Resistant Acinetobacer baumanni: the occurrence of polymyxin resistance in Rio de Janeiro. Visa in Debate: Society, Science and Technology, 4(3), 28-34. doi: 10.22239/2317-269X.00732
Guimarães, M. P. (2011). Occurrence of carbapenem-resistant Acinetobacter baumannii in pneumonia associated with mechanical ventilation in a mixed adult intensive care unit of a Brazilian university hospital: risk factors and prognosis. Master's Dissertation, Postgraduate Program in Applied Immunology and Parasitology, Federal University of Uberlândia, Minas Gerais, Uberlândia, MG, Brazil
Gurgel, T. C., & Carvalho, W. S. (2008). Pharmaceutical assistance and increased bacterial resistance to antimicrobials. Latin American Journal of Pharmacy, 27(1), 118-23. Retrieved from http://www.biologia.seed.pr.gov.br/arquivos/File/biotecnologia/resistencia_bacteriana_antimicrobianos.pdf
Higgins, P. G., Pérez-Llarena, F. J., Zander, E., Fernández, A., Bou, G., & Seifert, H. (2013). OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 57(5), 2121–2126. doi:10.1128/AAC.02413-12
Lima, L. K. O. L., Pinto, J. C. G., Misael, L. S., Castro, R. B., Coelho, D. D., Benevides, D. V. L., Sousa, E. R. M. (2019). Evaluation of contamination by Acinetobacter spp. in an intensive care unit. Journal of Epidemiology and Infection Control, 9(3), 2238-3360. doi:10.17058/reci.v9i3.12510.
Lima, T. T. (2018). Multidrug-resistance in Acinetobacter baumannii and carbapenemases research at the Hospital and Municipal Maternity Uberlandia. Master's Dissertation, Federal University of Uberlândia, Minas Gerais, Uberlândia, MG, Brazil.
Leão, A. C. Q. (2015). Impact of Acinetobacter spp. bacteremia on survival of intensive care unit patients [Impacto das bacteremias por Acinetobacter spp. na sobrevida de pacientes internados em unidade de terapia intensiva]. Master's Dissertation, Faculty of Medicine, University of São Paulo - FMUSP, São Paulo, SP, Brazil.
Leoncio, J. M., Almeida, V. F., Ferrari, R. A. P., Capobiango, J. D., Kerbauy, G., & Tacla, M. T. G.M. (2019). Impact of healthcare-associated infections on the hospitalization costs of children. Revista da Escola de Enfermagem da USP, 53, e03486. doi:10.1590/s1980-220x2018016303486
Ministry of Health (Brazil). (2007). Pharmaceutical Assistance at SUS. Brasília: National Council of Health Secretaries - CONASS. Retrieved from http://bvsms.saude.gov.br/bvs/publicacoes/colec_progestores_livro7.pdf
Modesto, E. N., & Brito, D. V. D. (2019). Nosocomial infections in high risk newborns: resistance profile of Gram-Negative Bacteria. Revista Eletrônica Acervo Saúde, 11(7), e517. doi:10.25248/reas.e517.2019
Mota, F. S., Oliveira, H. A., & Souto, R. C. F. (2018). Profile and prevalence of antimicrobial resistance of negative-Gram bacteria isolated from intensive care patients. Revista Brasileira de Análises Clínicas, 50(3), 270-7. doi:10.21877/2448-3877.201800740
Nóbrega, M. S., Carmo Filho, J. R., & Pereira, M. S. (2013). Drug resistance evolution of Pseudomonas aeruginosa and Acinetobacter baumannii in intensive care units. Revista Eletrônica de Enfermagem, 15(3), 696-703.
Oliveira, A. C., & Damasceno, Q. S. (2010). Surfaces of the hospital environment as possible deposits of resistant bacteria: a review. Revista da Escola de Enfermagem da USP, 44(4), 1118-1123. doi:10.1590/S0080-62342010000400038
Pan American Health Organization - PAHO. (2017). WHO publishes list of bacteria for which new antibiotics are urgently needed. Retrieved from: https://www.paho.org/bra/index.php?option=com_content&view=article&id=5357:oms- publica-lista-de-bacterias-para-as-quais-se-necessitam-novos-antibioticos- urgentemente&Itemid=812
Pagano, M., Martins, A. F., & Barth, A. L. (2016). Mobile genetic elements related to carbapenem resistance in Acinetobacter baumannii. Brazilian journal of microbiology, 47(4), 785–792. doi:10.1016/j.bjm.2016.06.005
Paula, A. O., Salge, A. K. M., & Palos, M. A. P. (2017). Healthcare-associated Infections in neonatal intensive care units: an Integrative review. Enfermería Global, 45, 523-36. doi:10.6018/eglobal.16.1.238041
Pogue, J. M., Cohen, D. A., & Marchaim, D. (2015). Editorial commentary: Polymyxin-resistant Acinetobacter baumannii: urgent action needed. Clinical infectious, 60(9), 1304–1307. doi:10.1093/cid/civ044
Ranjbar, R., Tolon, S. S., Zayeri, S., & Sami, M. (2018). The Frequency of Antibiotic Resistance and ESBLs Among Clinically Acinetobacter baumannii Strains Isolated from Patients in a Major Hospital in Tehran, Iran. The open microbiology journal, 12, 254–260. doi:10.2174/1874285801812010254
Roberts, R. R., Hota, B., Ahmad, I., Scott, R. D., 2nd, Foster, S. D., Abbasi, F., Schabowski, S., Kampe, L. M., Ciavarella, G. G., Supino, M., Naples, J., Cordell, R., Levy, S. B., & Weinstein, R. A. (2009). Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clinical infectious diseases, 49(8), 1175–1184. doi:10.1086/605630
Romanin, P., Palermo, R. L., Cavalini, J.F., Favaro, L. S., Petroli, S. B. P., Fernandes, E. V., Szczerepa, M. M. A., Tognim, M. C. B., Yamada-Ogatta, S. F., Marroni, F. E. C. & Yamauch, L. M. (2019). Multidrug- and Extensively Drug-Resistant Acinetobacter baumannii in a Tertiary Hospital from Brazil: The Importance of Carbapenemase Encoding Genes and Epidemic Clonal Complexes in a 10-Year Study. Microb Drug Resist, 25(9), 1365-1373. doi:10.1089/mdr.2019.0002
Santos, K. C., Barbosa, M. J., Araújo, W. N. M.S., Sena, V.V., & Souza, Q. T. (2019). Performance of the Clinical and Hospital Pharmacy in the Management of Antimicrobial Use in Public Hospital of DF. Revisa, 8(2), 153-9. doi:10.36239/revisa.v8.n2.p153a159
Silva, E. D. (2017). Incidence of Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa, in clinical samples of patients treated in a University Hospital, Monography. Clinical Microbiology Program of Ribeirão Preto, University of São Paulo - USP, São Paulo, Ribeirão Preto, SP, Brazil.
Silva, E. R. M. (2012). Analysis of the aspect of antimicrobials prescriptions at the medical clinic of a public hospital of Pará. Brazilian Journal of Hospital Pharmacy and Health Services, 3 (2), 15-19. Retrieved from: http://www.sbrafh.org.br/v1/public/artigos/2012030203BR.pdf
Sousa, M. I. C. (2018). Prevalence of multidrug-resistant infections by Acinetobacter baumannii in hospital and maternity hospital. Master's Dissertation, Federal University of Uberlândia, Minas Gerais, Uberlândia, MG, Brazil.
Vashist, J., Tiwari, V., Das, R., Kapil, A., & Rajeswari, M. R. (2011). Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii. The Indian journal of medical research, 133(3), 332–338. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103161/
Viana, M. M. (2013). Epidemiology of Acinetobacter baumannii health care related infection isolated from clinical specimens of patients admitted to a teaching hospital in Belém-PA: emphasis on sensitivity profile. Dissertation of Master, Institute of Biological Sciences and Health, Federal University of Pará - UFPA, Pará, Belém, PA, Brazil.
Veloso, D. S., Campelo, V., & Sá, T. L. B. (2017). Incidence of bacterial infections and antimicrobial profile used in the treatment of patients in a teaching hospital. Revista Interdisciplinar Ciências e Saúde, 4(2), 19-28. Retrieved from: https://revistas.ufpi.br/index.php/rics/article/view/5053
Ko, K. S., Suh, J. Y., Kwon, K. T., Jung, S. I., Park, K. H., Kang, C. I., Chung, D. R., Peck, K. R., & Song, J. H. (2007). High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. The Journal of antimicrobial chemotherapy, 60(5), 1163–1167. doi:10.1093/jac/dkm305
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Roberta Rosa de Souza; Maikiane Aparecida Nascimento; Rosana Brambilla Ederli; Elorraine Coutinho Mathias Santos; Ildeny Alves dos Santos; João Pedro Brambilla Ederli
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
